164 related articles for article (PubMed ID: 370536)
1. Safety of delayed leucovorin "rescue" following high-dose methotrexate in children.
Camitta BM; Holcenberg JS
Med Pediatr Oncol; 1978; 5(1):55-9. PubMed ID: 370536
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
[TBL] [Abstract][Full Text] [Related]
3. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
4. Substitution of l-leucovorin for d,l-leucovorin in the rescue from high-dose methotrexate treatment in patients with osteosarcoma.
Jaffe N; Jorgensen K; Robertson R; George M; Letvak L; Barrett G
Anticancer Drugs; 1993 Oct; 4(5):559-64. PubMed ID: 8292813
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
[TBL] [Abstract][Full Text] [Related]
6. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
[TBL] [Abstract][Full Text] [Related]
7. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate.
Jaffe N; Prudich J; Knapp J; Wang YM; Bowman R; Cangir A; Ayala A; Chuang V; Wallace S
J Clin Oncol; 1983 Jul; 1(7):428-31. PubMed ID: 6607977
[TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate: a critical reappraisal.
Ackland SP; Schilsky RL
J Clin Oncol; 1987 Dec; 5(12):2017-31. PubMed ID: 3316519
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
Cotter SM; Parker LM
Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
[TBL] [Abstract][Full Text] [Related]
11. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
Widemann BC; Balis FM; Kim A; Boron M; Jayaprakash N; Shalabi A; O'Brien M; Eby M; Cole DE; Murphy RF; Fox E; Ivy P; Adamson PC
J Clin Oncol; 2010 Sep; 28(25):3979-86. PubMed ID: 20679598
[TBL] [Abstract][Full Text] [Related]
12. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
[TBL] [Abstract][Full Text] [Related]
13. Vincristine in the etiology of toxicity of high-dose methotrexate therapy.
Ridgway D; Renholds DC; Neerhout RC; Wolff LJ
Cancer; 1980 Dec; 46(12):2571-2. PubMed ID: 6969624
[TBL] [Abstract][Full Text] [Related]
14. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
15. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
[TBL] [Abstract][Full Text] [Related]
16. Plasma phenylalanine: tyrosine ratios during high-dose methotrexate-citrovorum "rescue".
Hilton MA; Patel CC; Bertolone SJ; Kmetz DR; Clark LW
Med Pediatr Oncol; 1982; 10(4):389-95. PubMed ID: 6981054
[TBL] [Abstract][Full Text] [Related]
17. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
[TBL] [Abstract][Full Text] [Related]
18. High-dose methotrexate therapy with leucovorin rescue: in vitro investigations on human osteosarcoma cell lines.
Diddens H; Teufel T; Niethammer D
Cancer Chemother Pharmacol; 1987; 20(2):128-32. PubMed ID: 3499251
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes.
Beh SC; Kildebeck E; Narayan R; Desena A; Schell D; Rowe ES; Rowe V; Burns D; Whitworth L; Frohman TC; Greenberg B; Frohman EM
J Neurol Sci; 2017 Jan; 372():187-195. PubMed ID: 28017209
[TBL] [Abstract][Full Text] [Related]
20. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
Perez C; Wang YM; Sutow WW; Herson J
Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
